Product portfolio

Molecular Diagnostics

Together we can help transform testing and treatment

Our aim is to provide high-quality systems and assays to give you the confidence to provide high-performance testing in your own laboratory.  

At Roche, we are committed to continuously developing molecular diagnostics technologies in order to help improve diagnosis and treatment times for all patients.

 

Our commitment to quality

We are committed to Polymerase Chain Reaction (PCR) technology, we continue to demonstrate our commitment to scientific and clinical excellence. Our aim is to be the trusted choice in systems and assays across the industry. Our systems range from plasma/ blood screening, and viral load testing, to more recent advancements in Human Papillomavirus (HPV) primary screening and oncology testing with the cobas® EGFR Mutation Test v2. We hold our products to the highest performance standards to ensure you have confidence in every result.

 

Advanced assay design

Our consistent delivery of breakthroughs in advanced molecular diagnostics displays our commitment to investing in research and development. This investment allows us to stay ahead of constantly evolving diseases. We can also help you make the most appropriate treatment decisions for your patients.

 

Ensuring confidence in results

Results generated on Roche systems are proven to be standardised and comparable across all platforms.1 According to World Health Organisation (WHO) standards, our new assays are verified with high precision for accuracy and traceability. 

 

Solutions to meet your molecular diagnostic testing needs

The benefits of using Roche molecular diagnostics solutions

Roche provides high quality molecular diagnostics systems and assays to give you the opportunity to provide the best in testing within your own laboratory. 

 

We pride ourselves on our Polymerase Chain Reaction (PCR) technology, and we hold our products to the highest performance standards to provide labs with reliable testing solutions.

 

There are plenty of reasons to use Roche molecular diagnostics solutions:

 

  • Roche has consistently invested in research and development (R&D) for molecular diagnostics, allowing us to develop advanced assay design. Roche has invested in new assays, instruments, and enhancements through internal developments and external acquisitions.
  • Our new molecular assays are verified with high precision for accuracy and traceability (World Health Organisation standards).
  • Roche has a broad molecular assay menu for any testing requirement.
  • Our LDT solutions offer stand-alone systems to highly automated solutions.
  • Roche believes in workflow efficiency through automation and IT when it comes to advanced molecular diagnostics testing. Roche can work with you to help improve TAT, reduce errors, and create more efficient use of your space and manpower.
  • Roche specialists are here for you, always offering technical advice to help you get the most from your tests and systems.

 

Our commitment to excellence, corporate stability, and delivery of innovation makes Roche the ideal choice for the future of your lab. You can be confident that our products and applications will continue to be supported into the future, and that we will adapt as your needs change.

 

Contact us to receive the next generation of innovative solutions to empower healthcare providers across Great Britain, and transform the lives of patients worldwide.

 

  1. Performance evaluation of the new real-time PCR-based cobas® HCV assay for use on the cobas® 6800/8800 systems for the detection and quantification of HCV RNA - RING Study. Poster presented at AASLD, Nov 11-14, 2016, Boston, MA, USA.
  2. Iordanoaia N, et al. Cross-contamination compliance of cobas® p 612 pre-analytical system in use with cobas® 6800/8800 Systems. Declaration of Serology and NAT testing compliance. Poster presented at ISBT, Dubai, UAE, 2016 September

 

Found 0 results in
Filters
...
    ...